共 27 条
- [1] WENDELBOE A M, RASKOB G E., Global burden of thrombosis: epidemiologic aspects, Circulation Research, 118, 9, pp. 1340-1347, (2016)
- [2] YEUNG J, LI W J, HOLINSTAT M., Platelet signaling and disease: targeted therapy for thrombosis and other related diseases, Pharmacological Reviews, 70, 3, pp. 526-548, (2018)
- [3] EL HAOUARI M., Platelet oxidative stress and its relationship with cardiovascular diseases in type 2 diabetes mellitus patients, Current Medicinal Chemistry, 26, 22, pp. 4145-4165, (2019)
- [4] THON J N, ITALIANO J E., Platelets: production, morphology and ultrastructure, Handbook of Experimental Pharmacology, 210, pp. 3-22, (2012)
- [5] FRANCO A T, CORKEN A, WARE J., Platelets at the interface of thrombosis, inflammation, and cancer, Blood, 126, 5, pp. 582-588, (2015)
- [6] LINDEMANN S, KRAMER B, SEIZER P, Et al., Platelets, inflammation and atherosclerosis, Journal of Thrombosis and Haemostasis, 5, pp. 203-211, (2007)
- [7] FONTANA P, ZUFFEREY A, DAALI Y, Et al., Antiplatelet therapy: targeting the TxA<sub>2</sub> pathway, Journal of Cardiovascular Translational Research, 7, 1, pp. 29-38, (2014)
- [8] YUHKI K, KASHIWAGI H, KOJIMA F, Et al., Roles of prostanoids in the pathogenesis of cardiovascular diseases, International Angiology, 29, pp. 19-27, (2010)
- [9] PATRONO C, CIABATTONI G, DAVI G., Thromboxane biosynthesis in cardiovascular diseases, Stroke, 21, pp. IV130-IV133, (1990)
- [10] NAIK M U, PATEL P, DERSTINE R, Et al., Ask1 regulates murine platelet granule secretion, thromboxane A<sub>2</sub> generation, and thrombus formation, Blood, 129, 9, pp. 1197-1209, (2017)